Inovio Pharmaceuticals (INO) Posts Narrower than Expected Q2 Loss of 18c/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. QCOM
2. FDX
3. CBRS
4. USO
5. SPY
6. MU
7. KBH
8. HTZ
9. HON
10. JPM

Go back to Inovio Pharmaceuticals (INO) Posts Narrower than Expected Q2 Loss of 18c/Share

Aegis Capital Comments on Inovio (INO) Following Q2 Results; Cash Position Remains 'Solid'

August 11, 2014 11:05 AM EDT

Aegis Capital affirms Inovio Pharmaceuticals (AMEX: INO) at Buy with a target price of $19 following Q2 results and update released earlier Monday.

Analyst Ram Selvaraju commented, This morning, Inovio reported financial results for the second quarter of 2014. The firm closed the... More